Все публикации

0:02:56

Treating Primary Immunodeficiency

0:01:48

New Treatments in Development for Fabry Disease

0:05:58

The Pathophysiology of Galactosemia

0:01:49

CTCL: Challenges of Treating People of Color (Chapter 1)

0:06:15

Clinical Trial Update: Mavodelpar To Treat Primary Mitochondrial Myopathies (STRIDE Study)

0:01:28

The Difference Between a Geneticist and a Genetic Counselor

0:03:34

Primary Mitochondrial Myopathy Explained

0:01:55

Current Treatment Options for Children with Gaucher Disease Type 2

0:06:41

Rett Syndrome Research at the NINDS

0:04:06

Rett Syndrome and the National Institute of Neurological Disorder and Stroke (NINDS)

0:02:57

What is Alpha Mannosidosis

0:03:02

What Are Chronic Neutropenic Disorders?

0:01:59

Bernie Williams and the Power of Music to Help Patients with Rare Lung Disorders

0:03:23

Reducing Barriers to Participate in Clinical Trials

0:15:38

CTCL: Criteria to Diagnose, Counsel Patients, and Work-Up for Early-stage Mycosis Fungoides

0:05:01

Counseling Patients With T-Cell Dyscrasias (Chapter 2)

0:03:41

Criteria to Diagnose Mycosis Fungoides (Chapter 1)

0:05:46

Work Up for Early Stage Mycosis Fungoides (Chapter 3)

0:03:19

Baseball Legend Bernie Williams Discusses Interstitial Lung Diseases

0:05:43

Using siRNA to Treat Charcot-Marie-Tooth Disease Type 1A

0:06:38

Patient with HoFH Describes His Diagnostic Journey

0:04:39

Long Term Efficacy of Enzyme Replacement Therapy (ERT) in Gaucher Disease Type 1 and Type 3

0:04:23

Treating Gaucher Disease Type 3: A History Lesson

0:02:47

Gaucher Disease Type 1, Type 2, and Type 3 Explained